Press Releases
WuXi STA Launches First Continuous Manufacturing Line for Oral...
WuXi STA, a subsidiary of WuXi AppTec, announced that its first drug product Continuous Manufacturing (CM) line for oral solids is in operation at the...
Press Releases
Aptar Pharma Multidose Device Delivers Approved Human Monoclonal Antibody...
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that its VP7 nasal multidose device is the delivery...
Press Releases
Clinical trial platform provider encapsia welcomes new COO
Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer. Francis brings more than 20 years...
Drug Research
AGC Biologics and Gore Collaborate on New Protein A-based...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced a collaboration with W.L. Gore & Associates (Gore) that features Protein A...
Press Releases
HighTide Therapeutics and Quotient Sciences Announce Agreement to Conduct...
HighTide Therapeutics, Inc., a globally integrated clinical-stage biopharmaceutical company focusing on novel multifunctional therapeutics for metabolic and digestive diseases, and Quotient Sciences, a drug development...
Press Releases
Velocity Clinical Research acquires Meridian Clinical Research creating largest...
Velocity Clinical Research (“Velocity”), the leading integrated research site organization, announces its acquisition of Meridian Clinical Research for an undisclosed amount. The deal makes Velocity...
Press Releases
Pfizer and BioNTech Receive U.S. FDA EUA for...
Pfizer Inc. and BioNTech SE announced the U.S. FDA granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.